Navigation Links
Reportlinker Adds Trends and Strategies in Pharmaceutical and Medical Device Branding

NEW YORK, Sept. 9 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Trends and Strategies in Pharmaceutical and Medical Device Branding

It is interesting to consider "what if" the founders of Yahoo had stuck to the original name. Certainly we would not have the iconic logo and of course the memorable name the company has now. It might be pertinent to say that had the company entered the competitive fray as "Jerry's Guide to the World Wide Web" the search engine would hold a lowly position amongst the options users have today to search the internet. While Google dominates the sector and has a brand value of $32bn in the branding agency Interbrands' 2009 analysis of global brands, Yahoo! still posts a brand value of $5.1bn (the second ranking search engine in the analysis).

This is one of the many examples that can be cited as to the importance of a good brand name and of a strong overall brand to business success. The importance of effective branding has generally been lost to companies in the pharmaceutical, biotechnology and medical device industries. One reason for this is that unlike other industries companies in these sectors have been able to charge premium prices for their products. Of course with such high development costs they need to. However, in sectors outside these "life science" industries competition leads to an emphasis on differentiation based on price and therefore to a degree of commoditization which is ultimately unwelcome in most business sectors. Rather than differentiate through branding companies can be lulled into believing that price is the more effective differentiator. This may be fair for the supermarket sector but not for many others. As pressure has built on drug and medical device companies, based on governmental efforts to reduce healthcare spending, the importance of brand building efforts has been realized by some.

As people continue to search the internet for information related to health and disease, and as they increasingly engage in online conversation with fellow sufferers and physicians for support and advice on day-to-day management of their conditions they increasingly become "exposed" to the companies that actually make the drugs and devices that they use. Even so, it is perhaps true to say that while many people know of Viagra they probably still cannot name the company that manufactures the drug. How important is it anyway for patients to know about the drug and device products they use? The simple answer is that it is increasingly important, purely because of the information they seek and obtain online. When companies first started to use direct to consumer advertising an important concern was that doctors would be pressured by patients into prescribing certain drugs, against their better judgment.

As time has gone on these fears have subsided as physicians have stood firm and have been able to assert their positions as the decision makers in the patient-physician relationship based on their specialization and a clear understanding of what is best for a particular patient. It appears that more and more physicians, who themselves are becoming increasingly familiar with and utilising the power of online social networks, welcome dialogue with the more informed patient. An even more important point is that physician concerns on detailing practice by the pharmaceutical companies in particular requires clearer messaging and branding efforts. Pharma companies are finding it increasingly difficult to reach and engage with physicians despite the fact that the companies are spending in the region of $24bn a year on sales activities. Signs of declining returns on pharma's investment in its sales force have been seen for some years. The profit per drug rep visit fell 23% from 2004 to 2005 and for every 100 reps who visit a practice, 37 succeed in placing their products in the office's sample cabinet, and only 20 speak to a physician in person, according to Pricewaterhouse Coopers (Pharma 2020: Marketing the future - Which path will you take?). Physicians are demanding more unbiased information from sales reps but they also expect sales reps to be better informed and provide much more detailed information before they will consider prescribing a particular drug.

Misinformation in the past has dented physician confidence and trust in the pharmaceutical sales forces. Studies have shown that physicians are beginning to favour the gathering of drug information through online sources and this means that companies will need to look at satisfying that demand. They will do these increasingly through web-based services, notably electronic detailing, or e-detailing (this encompasses telephone support, online physician portals, video conferencing and online drug sample ordering). With respect to physician portals, the example of Pfizer's collaboration in 2007 with the Sermo physician-to-physician network is a good one of how pharma companies are trying to engage and inform physicians about their drug products using Web 2.0 technology. It will also be important for drug and device companies to manage and utilise key opinion leader networks and merge word of mouth marketing with social media and social networking strategies in marketing efforts, so that all the healthcare practitioners who have a say in drug and device usage are targeted. All the touch points between the healthcare practitioner and the brand need to be identified and targeted for optimal information sharing and optimal use of sales and marketing spend.

As companies master this they will be better able to identify healthcare practitioner-specific issues and act in a proactive manner to improve the effectiveness of their marketing efforts. This report will address and show the issues which are critical in branding approaches for the pharma and medical device sectors. The report will look at the strategies that can be deployed to overcome physician resistance to pharma detailing and how companies can confront reservations with biased information exchange between pharma, biotech and medical reps and physicians, patients and financial administrators. Additionally, it is important to understand how certain pharma and medical device companies are using social marketing and word-of-mouth advertising to enhance the prestige and recognition of their brands. What role does the use of digital media play in generating brand exposure and brand recognition? How can digital media be used to protect the brand image? Examining the core concepts of branding this report, through a combination of primary and secondary research, will take the reader from what a brand was, to what it has become and what it should be within the medical device and pharma sectors.

Table of Contents1. Executive Summary 5<5

2. Introduction 8

2.1. Spiralling health care costs in the US – no sign of abatement 9

2.1.1. Drug spending an easy target for cost cutting measures 9

2.1.2. Detailing negatively affects pharmaceutical industry image 10

2.1.3. Cost pressures lead to reduction in US Pharma sales forces 12

2.1.4. A need for better, more informed detailing practice 12

2.2. Indications of marketing spend shifting towards the internet 13

2.2.1. EU consumer advertising of pharmaceuticals. 15

2.3. Dwelling on the positives, address the negatives 16

2.3.1. Monitoring DTC advertising of medical devices 18

3. What is a brand? 22

3.1. The history of the brand 23

3.2. The benefits of the brand 25

3.2.1. The importance of brand equity 26

3.2.2. The importance of brand naming 28

4. Brand architecture 35

4.1. The story is crucial 35

4.1.1 Brand Architecture Models 37

4.2. Defining brand architecture strategy 41

4.2.1. Product specifics 41

4.2.2. Product placement 44

4.2.3. Ansoff Matrix 44

4.2.4. Brand archetypes 47

4.2.5. Boston Matrix 48

5 Marketing strategies – Corporate vs product branding 54

5.1 The global brand 54

5.2 Branding the company 58

5.3 Branding the product - Timing strategies to fit within the Medtech/Pharma product lifecycle 61

5.4 Brand building – different strokes for different folks 65

5.4.1 Philips - building momentum and success through development of the core brand. 66

5.4.2 Medtronic focuses on the corporate brand 67

5.4.3 Nuvasive – heightened competition dictates corporate brand emphasis 68

5.4.4 KCI – first mover advantage advocates the product branding route 70

5.5 Establishing effective brand recognition 70

5.5.1 Fashionable Medical Devices - Creating a positive brand experience 75

6 Branding Clinical Trials 80

6.1 Mass media promotion – big business 80

6.1.1 Branding clinical trials for subject recruitment 80

6.2 Clinical trial branding strategies 83

6.2.1 Branding clinical trials for investor confidence 85

6.2.2 Branding clinical trials for cohesion 87

6.2.3 Branding clinical trials for medical devices 90

7 E-branding. Maximising a web presence 95

7.1 Trusting the e-brand 96

7.1.1 Indicators of a trustworthy website 98

7.2 Promoting the medical device e-brand effectively 100

7.2.1 Promoting the medical device e-brand to the patient 102

7.3 Social media networks 106

7.3.1 Using social networking in promoting the e-brand to patients 109

7.3.2 Device and pharma wary of regulations 110

7.4.1 What has the creation of a safe place to do with strengthening a brand? 113

7.5 Promoting the e-brand to the physician 119

7.5.1 Using social networking in promoting the e-brand to physicians 121

7.6 Is there a difference between Facebook and Twitter? 122

7.7 Summarizing the e-brand 126

8 Word of Mouth Marketing 129

8.1 Trust: its role in interpersonal communications 130

8.2 Chaos Theory – its importance in WOM strategies 132

8.2.1 The Stickiness Factor – Abbott's Labs are Vital campaign 135

8.3 Product Diffusion: Role of Opinion Leadership and Social Contagion 135

8.3.1 Homophily 137

8.4 WOM and Cross-Brand and Within-Brand Influence 139

9 How to protect a brand 1419.1 Working With Doctors to Maintain the Strength of Your Brands 14610 Steps to brand creation and promotion 148APPENDIX 150To order this report:Pharmaceutical Industry: Trends and Strategies in Pharmaceutical and Medical Device Branding

Pharmaceutical Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: US: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
(Date:7/31/2017)... -- Three Tru-D SmartUVC robots have arrived at Brian Allgood ... Tru-D, short for "Total Room Ultraviolet Disinfection," is a 5-foot-5 germ-killing robot ... (ES) professional cleans the area with traditional cleaning protocols. ... Tru-D fights germs at Army hospitals ... "Although the BAACH has a very low infection rate, ...
(Date:7/27/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported ... The Company reported second quarter net sales of $1.954 ... period, and an increase of 2.1% on a constant ... from the LDR Holding Corporation acquisition, second quarter 2017 ... or 0.3% on a constant currency basis. ...
(Date:7/26/2017)... BEACH, Fla. , July 26, 2017 ... of enrollment of our clinical trial evaluating Altemia TM ... Cell Anemia (SCA) and Sickle Cell Disease (SCD). The ... to evaluate the efficacy and safety of Altemia TM ... trial is conducted under US IND 125274. ...
Breaking Medicine Technology:
(Date:8/16/2017)... Texas (PRWEB) , ... August 16, 2017 , ... Ten ... Credit Union's Stars in the Classroom and will win a visit by a Houston ... grades K-12 who are at least five years old can visit to nominate ...
(Date:8/16/2017)... ATLANTA, Georgia (PRWEB) , ... August 16, 2017 ... ... practice in Atlanta, opened their doors. They celebrate 30 years in business this ... to create an up-to-date, inviting, tranquil space to serve their patients. , ...
(Date:8/16/2017)... ... August 16, 2017 , ... Maury Regional Health has announced a ... By broadly deploying AccuVein devices, Maury Regional Medical Center is making vein visualization part ... of a needle stick and more importantly, helps our staff members locate a vein ...
(Date:8/16/2017)... New Cumberland, PA (PRWEB) , ... August 16, 2017 , ... ... announced today it has successfully opened clubfoot clinics in all 29 Indian states—bringing the ... its newest clinic in Kangra, Himachal Pradesh, the nonprofit organization is on track to ...
(Date:8/16/2017)... ... August 16, 2017 , ... Fusion Flix Inc., a Telly ... over four countries and millions of viewers in a partnership with the Amazon Video ... On-Demand and fully available on Blu Ray disc in 2018. Proceeds will be going ...
Breaking Medicine News(10 mins):